PubRank

S Blankenberg

Author PubWeight™ 23.74‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the AtheroGene study. J Thromb Haemost 2007 1.67
2 The superiority of TIMI frame count in detecting coronary flow changes after coronary stenting compared to TIMI Flow Classification. J Invasive Cardiol 2002 1.54
3 Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation 2001 1.44
4 Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study. Arterioscler Thromb Vasc Biol 2006 1.23
5 Analysis of phenotype and genotype information for the diagnosis of Marfan syndrome. Clin Genet 2011 1.18
6 Association between P-selectin gene polymorphisms and soluble P-selectin levels and their relation to coronary artery disease. Arterioscler Thromb Vasc Biol 2001 1.18
7 [The Gutenberg Health Study]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2012 1.15
8 Are morphological or functional changes in the carotid artery wall associated with Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus, or herpes simplex virus infection? Stroke 2000 1.10
9 [Do we need even more new biomarkers?]. Dtsch Med Wochenschr 2013 0.97
10 Associations between interleukin-1 (IL-1) gene variations or IL-1 receptor antagonist levels and the development of type 2 diabetes. J Intern Med 2011 0.96
11 SELPLG gene polymorphisms in relation to plasma SELPLG levels and coronary artery disease. Ann Hum Genet 2003 0.96
12 Polymorphisms of the tumor necrosis factor-alpha (TNF) and the TNF-alpha converting enzyme (TACE/ADAM17) genes in relation to cardiovascular mortality: the AtheroGene study. J Mol Med (Berl) 2008 0.94
13 Comparison of QCA systems. Int J Card Imaging 1997 0.86
14 Tako-Tsubo syndrome: dying of a broken heart? Clin Res Cardiol 2010 0.85
15 Comprehensive analysis of dural ectasia in 150 patients with a causative FBN1 mutation. Clin Genet 2013 0.85
16 Dural ectasia in Loeys-Dietz syndrome: comprehensive study of 30 patients with a TGFBR1 or TGFBR2 mutation. Clin Genet 2013 0.83
17 Comparison of diagnostic performance of cardiac troponin I on the IMMULITE system with other automated troponin I assays in minor myocardial damage. Scand J Clin Lab Invest 2001 0.82
18 Symetis ACURATE TAVI: review of the technology, developments and current data with this self-expanding transcatheter heart valve. Minerva Cardioangiol 2015 0.81
19 Activated thrombin activatable fibrinolysis inhibitor levels are associated with the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study. J Thromb Haemost 2009 0.80
20 [Patient satisfaction in acute coronary syndrome. Improvement through the establishment of a chest pain unit]. Herz 2010 0.79
21 [The length of hospital stay in patients with acute coronary syndrome is reduced by establishing a chest pain unit]. Herz 2011 0.78
22 Transcatheter aortic valve implantation: alternative access options. Minerva Cardioangiol 2013 0.78
23 What's new in transapical aortic valve implantation: clinical experience with second generation devices. Minerva Cardioangiol 2013 0.76
24 Combining cross-sectional data on prevalence with risk estimates from a prediction model. A novel method for estimating the attributable risk. Methods Inf Med 2014 0.76
25 A simple clinical model to estimate the probability of Marfan syndrome. QJM 2012 0.76
26 [Personalized therapy in cardiology. Biomarkers, pharmacogenetics and therapy of monogenic diseases]. Internist (Berl) 2013 0.75
27 Analytical and clinical evaluation of troponin I determination on dimension RXL-HM. Clin Chem Lab Med 2000 0.75
28 [Effect of qualitative stenosis characteristics on the quality of measurements of various QCA systems]. Z Kardiol 1997 0.75
29 [Treating mitral regurgitation: a surgical and interventional update]. Herz 2011 0.75
30 [Immunactivation in chronic heart failure. Inflammatory mediators]. Z Kardiol 2004 0.75
31 [Acute coronary syndrome (without ST-elevation)]. Z Kardiol 2004 0.75
32 [Influence of impaired fasting glucose on the incidence and prognosis of atherosclerosis in various vascular regions]. Z Kardiol 2004 0.75
33 [Role of biomarkers for risk stratification in the prevention of cardiovascular diseases]. Dtsch Med Wochenschr 2009 0.75
34 [Prevalence and risk factors of atrial fibrillation in Germany : data from the Gutenberg Health Study]. Herz 2015 0.75
35 [Genet(h)ics: the philosophical concept of the discourse ethics and consequences for the research community]. Z Kardiol 2004 0.75